Pricing Log in Create free account

Celldex Therapeutics, Inc. (CLDX) vs Lakefront Biotherapeutics - Sponsored ADR (LKFT)

Celldex Therapeutics, Inc. and Lakefront Biotherapeutics - Sponsored ADR are both Biotechnology companies. Celldex Therapeutics, Inc. and Lakefront Biotherapeutics - Sponsored ADR are of similar size ($2.2B and $2.2B). Lakefront Biotherapeutics - Sponsored ADR grew revenue faster over the last twelve months: −52.2% against −88.3%. Lakefront Biotherapeutics - Sponsored ADR has the higher net margin (−6.81% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 15 and Celldex Therapeutics, Inc. on 2.

Valuation

Metric CLDX LKFT Biotechnology median
P/E n/m n/m 10.60
P/S 2,623.92 7.79 9.40
P/B 3.26 0.58 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.96 0.66
EV/Sales 1,817.76 (1.42) 9.02
Earnings yield (14.55%) (0.85%) (32.88%)
Free cash flow yield (10.40%) (27.14%) (23.13%)

Profitability

Metric CLDX LKFT Biotechnology median
Gross margin 100.00% 89.75% 68.51%
Operating margin (36,733.82%) (90.11%) 0.00%
Net margin (33,883.77%) (6.81%) 0.00%
Free cash flow margin (27,294.81%) 0.00% 0.00%
Return on equity (43.88%) 0.00% (51.96%)
Return on assets (40.76%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDX LKFT Biotechnology median
Revenue growth (TTM) (88.27%) (52.22%) 6.76%
EPS growth (last fiscal year) (59.18%) 355.37% 29.88%
Revenue growth, 5-year CAGR (26.93%) 15.75% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLDX LKFT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.82 32.84 4.97
Net debt to EBITDA 1.78 (8.53) 1.01

Dividend

Metric CLDX LKFT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLDX LKFT Biotechnology median
Market cap 2.22b 2.20b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack